Success Story: NIW Approval After RFE for a Molecular Biology and Biotechnology Researcher Advancing Molecular Diagnostics
Client’s Testimonial:
“Thanks so much for the entire process.”
On September 10th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Scientist in the Field of Molecular Biology and Biotechnology (Approval Notice).
General Field: Molecular Biology and Biotechnology
Position at the Time of Case Filing: Associate Scientist
Country of Origin: Bangladesh
Country of Residence at the Time of Filing: Bangladesh
Approval Notice Date: September 10th, 2026
Processing Time: 5 months, 25 days (Premium Processing Requested)
Case Summary:
Improving public health outcomes increasingly depends on diagnostic tools that are accurate, accessible, and adaptable to different clinical settings. The client’s research operates at the intersection of molecular biology, biotechnology, genetic testing, and infectious disease diagnostics, with a focus on developing molecular diagnostic assays that support earlier detection, precision diagnosis, and better clinical management of infectious and inherited diseases.
The client holds a Ph.D. in biological sciences and has built a research record focused on molecular diagnostic testing. At the time of filing, the client resided in Bangladesh, and the petition also documented plans to continue the proposed work through a senior research specialist role in genetic medicine at a U.S.-based academic institution. The proposed endeavor was framed around the development of cost-effective and sensitive diagnostic tools, including tests for infectious agents, pathogenic mutations, and inherited blood disorders.
The petition was supported by 3 expert recommendation letters, including 1 independent advisory opinion. These letters helped explain the broader public health value of the client’s work and confirmed the relevance of the client’s continued research in molecular diagnostics, genetic testing, and early disease detection. One expert noted:
"Therefore, it is my professional opinion that [Client] clearly merits the opportunity to continue her valuable work in the United States"
For National Interest Waiver petitions, the strongest cases demonstrate not only that a proposed endeavor serves an important national objective, but also that the researcher has already established a record showing the ability to advance that objective. North America Immigration Law Group (NAILG) structured the petition around exactly those considerations, demonstrating that the client’s contributions to molecular diagnostics, infectious disease testing, and genetic disorder screening had already influenced researchers working on public health, biotechnology, and clinical diagnostic methods.
NAILG organized the evidence so USCIS could evaluate impact through clear, objective indicators:
● Peer-review activity: at least 7 completed reviews for journals in molecular biology, biotechnology, and related biomedical fields.
● Publication record: 18 peer-reviewed journal articles, 1 peer-reviewed conference paper, 3 under-review journal articles, 4 preprints, and 1 first-authored book chapter.
● Citation reliance: cited 639 times by researchers.
The petition did not rely on numbers alone. We placed the client’s citation record in context by showing that 1 of the client’s publications ranked among the top 10% most-cited Molecular Biology and Genetics articles for its publication year. We also showed that independent researchers had relied on the client’s work in later studies involving inherited blood disorder screening, infectious disease testing, anemia-related analysis, and molecular diagnostic methods.
After USCIS issued an RFE, the response focused on connecting the client’s research record to the Dhanasar framework. We emphasized the national importance of improving access to molecular diagnostic tools, the client’s strong positioning through education, publication history, citation impact, peer-review service, and expert support, and the benefit of allowing the client to continue work in a field with public health and biotechnology significance.
USCIS approved the client’s I-140 NIW petition after an RFE, recognizing a record defined by meaningful scholarly influence, independent reliance by other researchers, trusted peer-review service, expert support, and sustained contributions to molecular diagnostics. This approval supports the client’s continued work in advancing accessible, accurate, and clinically useful diagnostic technologies in the United States.